News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael J. Fine, MD

Articles by Michael J. Fine, MD

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

ByRobert Zivadinov, MD, PhD,Michael J. Fine, MD,Krishna R. Patel, PharmD, RPh,Neil Minkoff, MD

January 25th 2022

Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)

ByJeffrey L. Cummings, MD, ScD,Michael J. Fine, MD,Igor D. Grachev, MD, PhD,C. Rick Jarecke, PharmD,Meridith K. Johnson, MSc,Phillip H. Kuo, MD, PhD,Joyce A. Oberdorf,Michael Rezak, MD, PhD,Da

March 24th 2014

Cost of Care for Malignant and Benign Renal Masses

ByAviva G. Asnis-Alibozek, PA-C,Michael J. Fine, MD,Paul Russo, MD,Trent McLaughlin, BSc(Pharm), PhD,Eileen M. Farrelly, MPH,Norman LaFrance, MD,William Lowrance, MD, MPH

August 12th 2013

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.

Latest Updated Articles

Cost of Care for Malignant and Benign Renal Masses
Published: August 12th 2013 | Updated:
Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)
Published: March 24th 2014 | Updated:

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC

Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD

Flow Cytometry Tool Could Improve Treatment Monitoring in MS

Systemic Barriers in Patients’ Weight Loss Journey: David Rometo, MD

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.